The DOI matches its Crossref record; 275 of the 275 references it cites were found in a registry or an index.
BRCA1 gene in breast cancer
Open accessAbstract
The BRCA1 gene was identified and cloned in 1994 based its linkage to early onset breast cancer and breast‐ovarian cancer syndromes in women. While inherited mutations of BRCA1 are responsible for about 40–45% of hereditary breast cancers, these mutations account for only 2‐3% of all breast cancers, since the BRCA1 gene is rarely mutated in sporadic breast cancers. However, BRCA1 expression is frequently reduced or absent in sporadic cancers, suggesting a much wider role in mammary carcinogenesis. Since BRCA1 was cloned in 1994, its molecular function has been the subject of intense investigation. These studies have revealed multiple functions of the BRCA1 that may contribute to its tumor suppressor activity, including roles in: cell cycle progression, several highly specialized DNA repair processes, DNA damage‐responsive cell cycle checkpoints, regulation of a set of specific transcriptional pathways, and apoptosis. Many of these functions are linked to protein:protein interactions involving different portions of the 1,863 amino acid (aa) BRCA1 protein. BRCA1 functions in cell cycle progression and the DNA damage response appear to be regulated by distinct and specific phosphorylation events, but the molecular pathways activated by these phosphorylations are only beginning to be unraveled. In addition, the reason that BRCA1 mutation carriers develop specific tumor types (breast and ovarian cancers in women and possibly prostate cancers in men) is not clearly understood. Elucidation of the precise molecular functions of the BRCA1 gene product will greatly enhance our understanding of the pathogenesis of hereditary as well as sporadic mammary carcinogenesis. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
RetractedLeadon, S. A., & Avrutskaya, A. V. (1997) · PubMed · Cited by 78
RetractedBRCA1-induced Apoptosis Involves Inactivation of ERK1/2 Activities
Yan, Y., Haas, J. P., Kim, M., Sgagias, M. K., & Cowan, K. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201147200 · Cited by 50
RetractedLeadon, S. A., & Avrutskaya, A. V. (1998) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(98)00007-x · Cited by 42
RetractedGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“Gadd45 is a DNA damage-responsive gene that occurs in three isoforms (a, b, and g) and functions in DNA repair, cell cycle checkpoint mechanisms, and apoptosis pathways (Kastan et al., 1992; Jin et al., 2000b; Sheikh et al., 2000; Tran et al., 2002).”
BackgroundLinkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B., & King, M.-C. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,550
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850 · cited 3×
“Hereditary breast cancers account for 5–10% of all breast cancers, and inherited mutations of the BRCA1 gene account for about 40–45% of these hereditary cancers (Hall and Lee, 1990; Ford et al., 1994, 1995; Rowell et al., 1994; Easton et al., 1995).”
BackgroundBowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Gene-Expression Profiles in Hereditary Breast Cancer
Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Raffeld, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440801 · Cited by 1,733
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Genomic Instability in Mice Lacking Histone H2AX
Celeste, A., Petersen, S., Romanienko, P. J., Fernandez-Capetillo, O., Chen, H. T., Sedelnikova, O. A., Reina-San-Martin, B., Coppola, V., Meffre, E., Difilippantonio, M. J., et al. (2002) · Science · doi:10.1126/science.1069398 · Cited by 1,385
Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein
Shinohara, A., Ogawa, H., & Ogawa, T. (1992) · Cell · doi:10.1016/0092-8674(92)90447-k · Cited by 1,248
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Esteller, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.564 · Cited by 1,233 · cited 1×
“…about 10–15% of sporadic breast and ovarian cancer cases exhibit hyper-methylation of the BRCA1 promoter, associated with a reduction of BRCA1 mRNA expression (Baldwin et al., 2000; Esteller et al., 2000; Magdinier et al., 2000; Rice and Futscher, 2000; Rice et al., 2000; Chan et al., 2002).”
BackgroundWang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
BRCA1 Mutations in Primary Breast and Ovarian Carcinomas
Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., et al. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,205
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
The RAD9 Gene Controls the Cell Cycle Response to DNA Damage in Saccharomyces cerevisiae
Weinert, T. A., & Hartwell, L. H. (1988) · Science · doi:10.1126/science.3291120 · Cited by 1,156
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D.-S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,072
Buettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,040
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S., & Weissman, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11364 · Cited by 981
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Gain of function mutations in p53
Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., & Levine, A. J. (1993) · Nature Genetics · doi:10.1038/ng0593-42 · Cited by 894
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., & Stratton, M. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 873
DNA Repair Pathway Stimulated by the Forkhead Transcription Factor FOXO3a Through the Gadd45 Protein
Tran, H., Brunet, A., Grenier, J. M., Datta, S. R., Fornace, A. J., DiStefano, P. S., Chiang, L. W., & Greenberg, M. E. (2002) · Science · doi:10.1126/science.1068712 · Cited by 860
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-333 · Cited by 839
Lakhani, S. R., van de Vijver, M. J., Jacquemier, J., Anderson, T. J., Osin, P. P., McGuffog, L., & Easton, D. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.023 · Cited by 823
Xu, X., Weaver, Z., Linke, S. P., Li, C., Gotay, J., Wang, X.-W., Harris, C. C., Ried, T., & Deng, C.-X. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80466-9 · Cited by 819
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
Xu, X., Wagner, K.-U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A., & Deng, C.-X. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 758
A superfamily of conserved domains in DNA damage‐ responsive cell cycle checkpoint proteins
Bork, P., Hofmann, K., Bucher, P., Neuwald, A. F., Altschul, S. F., & Koonin, E. V. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034168 · Cited by 746
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M.-C. W., Hwang, L.-Y., Bowcock, A. M., & Baer, R. (1996) · Nature Genetics · doi:10.1038/ng1296-430 · Cited by 746
Jensen, D. E., Proctor, M., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201861 · Cited by 723
Harris, J. R., Lippman, M. E., Veronesi, U., & Willett, W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270505 · Cited by 701
Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00304-x · Cited by 674
The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse
Hakem, R., de la Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81302-1 · Cited by 667
Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., & Brody, L. C. (1995) · Nature Genetics · doi:10.1038/ng1095-198 · Cited by 647
Does this have a familiar RING?
Saurin, A. J., Borden, K. L. B., Boddy, M. N., & Freemont, P. S. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)80017-x · Cited by 635
Hashizume, R., Fukuda, M., Maeda, I., Nishikawa, H., Oyake, D., Yabuki, Y., Ogata, H., & Ohta, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000881200 · Cited by 634
Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80276-2 · Cited by 633
Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1999) · Science · doi:10.1126/science.285.5428.747 · Cited by 626
Friedman, L. S., Ostermeyer, E. A., Szabo, C. I., Dowd, P., Lynch, E. D., Rowell, S. E., & King, M.-C. (1994) · Nature Genetics · doi:10.1038/ng1294-399 · Cited by 622
ATM and ATR: networking cellular responses to DNA damage
Shiloh, Y. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00159-3 · Cited by 601
Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L., & Holt, J. T. (1995) · Nature Genetics · doi:10.1038/ng0495-444 · Cited by 585
Unusual case of Smith‐Lemli‐Opitz syndrome “type II”
Seller, M. J., Russell, J., & Tint, G. S. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560305 · Cited by 585
Bhattacharyya, A., Ear, U. S., Koller, B. H., Weichselbaum, R. R., & Bishop, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000276200 · Cited by 583
Stratton, M. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10109-4 · Cited by 579
Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1
Harkin, D. P., Bean, J. M., Miklos, D., Song, Y.-H., Truong, V. B., Englert, C., Christians, F. C., Ellisen, L. W., Maheswaran, S., Oliner, J. D., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80769-2 · Cited by 557
BRCA1 Is Associated with a Human SWI/SNF-Related Complex
Bochar, D. A., Wang, L., Beniya, H., Kinev, A., Xue, Y., Lane, W. S., Wang, W., Kashanchi, F., & Shiekhattar, R. (2000) · Cell · doi:10.1016/s0092-8674(00)00030-1 · Cited by 546
Induction of apoptosis in HeLa cells by trans-activation-deficient p53.
Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., & Oren, M. (1995) · Genes & Development · doi:10.1101/gad.9.17.2170 · Cited by 545
Involvement of Brca1 in S-Phase and G 2 -Phase Checkpoints after Ionizing Irradiation
Xu, B., Kim, S.-T., & Kastan, M. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3445-3450.2001 · Cited by 540
Wong, A. K. C., Pero, R., Ormonde, P. A., Tavtigian, S. V., & Bartel, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.31941 · Cited by 539
Ludwig, T., Chapman, D. L., Papaioannou, V. E., & Efstratiadis, A. (1997) · Genes & Development · doi:10.1101/gad.11.10.1226 · Cited by 539
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
Lee, J.-S., Collins, K. M., Brown, A. L., Lee, C.-H., & Chung, J. H. (2000) · Nature · doi:10.1038/35004614 · Cited by 529
Ford, D., Easton, D. F., & Peto, J. (1995) · Europe PMC (PubMed Central) · Cited by 528
Thorlacius, S., Olafsdottir, G., Tryggvadottir, L., Neuhausen, S., Jonasson, J. G., Tavtigian, S. V., Tulinius, H., Ögmundsdottir, H. M., & Eyfjörd, J. E. (1996) · Nature Genetics · doi:10.1038/ng0596-117 · Cited by 525
CtBP, an Unconventional Transcriptional Corepressor in Development and Oncogenesis
Chinnadurai, G. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00443-4 · Cited by 523
Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells
Pierce, A. J., Hu, P., Han, M., Ellis, N., & Jasin, M. (2001) · Genes & Development · doi:10.1101/gad.946401 · Cited by 514
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
Tibbetts, R. S., Cortez, D., Brumbaugh, K. M., Scully, R., Livingston, D., Elledge, S. J., & Abraham, R. T. (2000) · Genes & Development · doi:10.1101/gad.851000 · Cited by 512
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.
Brzović, P. S., Rajagopal, P., Hoyt, D. W., King, M., & Klevit, R. E. (2001) · Nature Structural Biology · doi:10.1038/nsb1001-833 · Cited by 511
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl
Somasundaram, K., Zhang, H., Zeng, Y.-X., Houvras, Y., Peng, Y., Zhang, H., Wu, G. S., Licht, J. D., Weber, B. L., & El-Deiry, W. S. (1997) · Nature · doi:10.1038/38291 · Cited by 509
DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?
Durocher, D., & Jackson, S. P. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00201-5 · Cited by 500
Gayther, S. A., Warren, W., Mazoyer, S., Russell, P. A., Harrington, P. A., Chiano, M., Seal, S., Hamoudi, R., van Rensburg, E. J., Dunning, A. M., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-428 · Cited by 496
BRCA1 physically associates with p53 and stimulates its transcriptional activity
Zhang, H., Somasundaram, K., Peng, Y., Tian, H., Zhang, H., Bi, D., Weber, B. L., & El-Deiry, W. S. (1998) · Oncogene · doi:10.1038/sj.onc.1201932 · Cited by 492
BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells
Fan, S., Wang, J.-A., Yuan, R., Ma, Y., Meng, Q., Erdos, M. R., Pestell, R. G., Yuan, F., Auborn, K. J., Goldberg, I. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1354 · Cited by 491
Self-citationBRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage
Yarden, R. I., Pardo-Reoyo, S., Sgagias, M., Cowan, K. H., & Brody, L. C. (2002) · Nature Genetics · doi:10.1038/ng837 · Cited by 484
Zhan, Q., Lord, K. A., Alamo, I., Hollander, M. C., Carrier, F., Ron, D., Kohn, K. W., Hoffman, B., Liebermann, D. A., & Fornace, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2361 · Cited by 482
Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities
Gowen, L. C., Johnson, B. L., Latour, A. M., Sulik, K. K., & Koller, B. H. (1996) · Nature Genetics · doi:10.1038/ng0296-191 · Cited by 480
A unified view of the DNA-damage checkpoint
Melo, J., & Toczyski, D. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00312-5 · Cited by 457
BRCA1 is a component of the RNA polymerase II holoenzyme
Scully, R., Anderson, S. F., Chao, D. M., Wei, W., Ye, L., Young, R. A., Livingston, D. M., & Parvin, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5605 · Cited by 454
Evidence for a transcriptional activation function of BRCA1 C-terminal region
Monteiro, A. N. A., August, A., & Hanafusa, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13595 · Cited by 446
Gayther, S. A., Mangion, J., Russell, P., Seal, S., Barfoot, R., Ponder, B. A. J., Stratton, M. R., & Easton, D. (1997) · Nature Genetics · doi:10.1038/ng0197-103 · Cited by 442
Transcriptional activation by BRCA1
Chapman, M. S., & Verma, I. M. (1996) · Nature · doi:10.1038/382678a0 · Cited by 436
Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation
Connor, F., Bertwistle, D., Mee, P. J., Ross, G. M., Swift, S., Grigorieva, E., Tybulewicz, V. L. J., & Ashworth, A. (1997) · Nature Genetics · doi:10.1038/ng1297-423 · Cited by 432
Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas
Wilson, C. A., Ramos, L., Villaseñor, M. R., Anders, K. H., Press, M. F., Clarke, K., Karlan, B., Chen, J.-J., Scully, R., Livingston, D., et al. (1999) · Nature Genetics · doi:10.1038/6029 · Cited by 414
Menssen, A., & Hermeking, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082005599 · Cited by 406
p300 is a component of an estrogen receptor coactivator complex.
Hanstein, B., Eckner, R., DiRenzo, J., Halachmi, S., Liu, H., Searcy, B., Kurokawa, R., & Brown, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11540 · Cited by 396
BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A
Anderson, S. F., Schlegel, B. P., Nakajima, T., Wolpin, E. S., & Parvin, J. D. (1998) · Nature Genetics · doi:10.1038/930 · Cited by 393
Yu, X., Wu, L. C., Bowcock, A. M., Aronheim, A., & Baer, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25388 · Cited by 389
Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13
Easton, D. F., Steele, L., Fields, P., Ormiston, W., Averill, D., Daly, P. A., McManus, R., Neuhausen, S. L., Ford, D., Wooster, R., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/513891 · Cited by 387
Germ-Line BRCA1 Mutations in Jewish and Non-Jewish Women with Early-Onset Breast Cancer
FitzGerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., Silva-Arrieto, S., Finkelstein, D. M., Beer-Romero, P., Englert, C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601183340302 · Cited by 385
Moynahan, M. E., Cui, T. Y., & Jasin, M. (2001) · PubMed · Cited by 382
Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M., Haas, B., Norton, L., Borgen, P., Jhanwar, S., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-188 · Cited by 381
BRCA1 regulates p53-dependent gene expression
Ouchi, T., Monteiro, A. N. A., August, A., Aaronson, S. A., & Hanafusa, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2302 · Cited by 375
Xu, X., Qiao, W., Linke, S. P., Cao, L., Li, W.-M., Furth, P. A., Harris, C. C., & Deng, C.-X. (2001) · Nature Genetics · doi:10.1038/90108 · Cited by 373
Koonin, E. V., Altschul, S. F., & Bork, P. (1996) · Nature Genetics · doi:10.1038/ng0796-266 · Cited by 368
BRCA2 germline mutations in male breast cancer cases and breast cancer families
Couch, F. J., Farid, L. M., DeShano, M. L., Tavtigian, S. V., Calzone, K., Campeau, L., Peng, Y., Bogden, B., Chen, Q., Neuhausen, S., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-123 · Cited by 363
Growth retardation and tumour inhibition by BRCA1
Holt, J. T., Thompson, M. E., Szabo, C., Robinson-Benion, C., Arteaga, C. L., King, M.-C., & Jensen, R. A. (1996) · Nature Genetics · doi:10.1038/ng0396-298 · Cited by 361
Ruffner, H., Joazeiro, C. A. P., Hemmati, D., Hunter, T., & Verma, I. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081068398 · Cited by 359
Abeliovich, D., Kaduri, L., Lerer, I., Weinberg, N., Amir, G., Sagi, M., Zlotogora, J., Heching, N. I., & Peretz, T. (1997) · Europe PMC (PubMed Central) · Cited by 357
Tirkkonen, M., Johannsson, O. T., Agnarsson, B. A., Olsson, H. L., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J. J., Barkardottir, R. B., Borg, Å., et al. (1997) · PubMed · Cited by 354
Tumour biological features of BRCA1-induced breast and ovarian cancer
Jóhannsson, Ó. T., Idvall, I., Anderson, C., Borg, Å., Barkardóttir, R. B., Egilsson, V., & Olsson, H. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)89007-7 · Cited by 345
Liao, D. J., & Dickson, R. B. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070143 · Cited by 343
Shaulian, E., Zauberman, A., Ginsberg, D., & Oren, M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5581 · Cited by 342
Marquis, S. T., Rajan, J. V., Wynshaw-Boris, A., Xu, J., Yin, G.-Y., Abel, K. J., Weber, B. L., & Chodosh, L. A. (1995) · Nature Genetics · doi:10.1038/ng0995-17 · Cited by 336
Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response
Li, S., Ting, N. S. Y., Zheng, L., Chen, P.-L., Ziv, Y., Shiloh, Y., Lee, E. Y.-H. P., & Lee, W.-H. (2000) · Nature · doi:10.1038/35018134 · Cited by 335
BRCA1 interacts with components of the histone deacetylase complex
Yarden, R. I., & Brody, L. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4983 · Cited by 330
BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
Baldwin, R. L., Nemeth, E., Tran, H., Shvartsman, H. S., Cass, I. A., Narod, S. A., & Karlan, B. Y. (2000) · PubMed · Cited by 324
Liu, C. Y., Flesken-Nikitin, A., Li, S., Zeng, Y., & Lee, W. H. (1996) · Genes & Development · doi:10.1101/gad.10.14.1835 · Cited by 323
Tutt, A., Gabriel, A., Bertwistle, D., Connor, F., Paterson, H., Peacock, J., Ross, G., & Ashworth, A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80479-5 · Cited by 321
The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.
Wang, X. W., Vermeulen, W., Coursen, J. D., Gibson, M., Lupold, S. E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J. H., et al. (1996) · Genes & Development · doi:10.1101/gad.10.10.1219 · Cited by 313
BRCA1 is associated with the centrosome during mitosis
Hsu, L.-C., & White, R. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.12983 · Cited by 310
Aberrant Subcellular Localization of BRCA1 in Breast Cancer
Chen, Y., Chen, C.-F., Riley, D. J., Allred, D. C., Chen, P.-L., Von Hoff, D., Osborne, C. K., & Lee, W.-H. (1995) · Science · doi:10.1126/science.270.5237.789 · Cited by 309
Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice
Bradlow, H. L., Michnovicz, J. J., Telang, N. T., & Osborne, M. P. (1991) · Carcinogenesis · doi:10.1093/carcin/12.9.1571 · Cited by 304
Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
Williams, R. S., Green, R., & Glover, J. N. M. (2001) · Nature Structural Biology · doi:10.1038/nsb1001-838 · Cited by 297
Harris, J. R., Lippman, M. E., Veronesi, U., & Willett, W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208063270606 · Cited by 296
Brca2 is required for embryonic cellular proliferation in the mouse.
Suzuki, A., de la Pompa, J. L., Hakem, R., Elia, A., Yoshida, R., Mo, R., Nishina, H., Chuang, T., Wakeham, A., Itie, A., et al. (1997) · Genes & Development · doi:10.1101/gad.11.10.1242 · Cited by 287
Paull, T. T., Cortez, D., Bowers, B., Elledge, S. J., & Gellert, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111125998 · Cited by 282
Hutchinson, J., Jin, J., Cardiff, R. D., Woodgett, J. R., & Muller, W. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2203-2212.2001 · Cited by 280
Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1.
Smith, T. M., Lee, M. K., Szabo, C. I., Jerome, N., McEuen, M., Taylor, M., Hood, L., & King, M. C. (1996) · Genome Research · doi:10.1101/gr.6.11.1029 · Cited by 275
Chen, Y., Farmer, A. A., Chen, C., Jones, D. C., Chen, P., & Lee, W. (1996) · PubMed · Cited by 267
Narod, S. A., Ford, D., Devilee, P., Barkardottir, R. B., Lynch, H. T., Smith, S. A., Ponder, B. A. J., Weber, B. L., Garber, J. E., & Birch, J. M. (1995) · Europe PMC (PubMed Central) · Cited by 265
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
Fan, S., Ma, Y. X., Wang, C., Yuan, R.-Q., Meng, Q., Wang, J.-A., Erdos, M., Goldberg, I. D., Webb, P., Kushner, P. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204073 · Cited by 263
Self-citationPlacebo-Controlled Trial of Indole-3-Carbinol in the Treatment of CIN
Bell, M. C., Crowley-Nowick, P., Bradlow, H. L., Sepkovic, D. W., Schmidt-Grimminger, D., Howell, P., Mayeaux, E. J., Tucker, A., Turbat-Herrera, E. A., & Mathis, J. M. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5847 · Cited by 262
Xia, F., Taghian, D. G., DeFrank, J. S., Zeng, Z.-C., Willers, H., Iliakis, G., & Powell, S. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151253498 · Cited by 262
The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity
Baer, R. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00269-6 · Cited by 260
Partial rescue of Brca15–6 early embryonic lethality by p53 or p21 null mutation
Hakem, R., de la Pompa, J. L., Elia, A., Potter, J., & Mak, T. W. (1997) · Nature Genetics · doi:10.1038/ng0797-298 · Cited by 252
Genomic integrity and the repair of double-strand DNA breaks
Pastink, A., Eeken, J. C. J., & Lohman, P. H. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00167-1 · Cited by 247
BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells
Wang, Q., Zhang, H., Kajino, K., & Greene, M. I. (1998) · Oncogene · doi:10.1038/sj.onc.1202403 · Cited by 243
The Protein Family of RNA Helicases
Lüking, A., Stahl, U., & Schmidt, U. (1998) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239891204233 · Cited by 243
Barnes, D. M., & Gillett, C. E. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006103831990 · Cited by 243
Armes, J. E., Trute, L., White, D., Southey, M. C., Hammet, F., Tesoriero, A. A., Hutchins, A., Dite, G. S., McCredie, M. R. E., Giles, G. G., et al. (1999) · PubMed · Cited by 236
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
de Jong, M. M., Nolte, I. M., te Meerman, G. J., van der Graaf, W. T. A., Oosterwijk, J. C., Kleibeuker, J. H., Schaapveld, M., & de Vries, E. G. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.4.225 · Cited by 235
BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair
Hartman, A.-R., & Ford, J. M. (2002) · Nature Genetics · doi:10.1038/ng953 · Cited by 233
Zheng, L., Pan, H., Li, S., Flesken-Nikitin, A., Chen, P.-L., Boyer, T. G., & Lee, W.-H. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00075-7 · Cited by 232
Localization of BRCA1 and a Splice Variant Identifies the Nuclear Localization Signal
Thakur, S., Zhang, H. B., Peng, Y., Le, H., Carroll, B., Ward, T., Yao, J., Farid, L. M., Couch, F. J., Wilson, R. B., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.444 · Cited by 231
Rice, J. C., Ozcelik, H., Maxeiner, P., Andrulis, I., & Futscher, B. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.9.1761 · Cited by 229
Abbott, D. W., Thompson, M. E., Robinson-Benion, C., Tomlinson, G., Jensen, R. A., & Holt, J. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18808 · Cited by 228
CBP/p300 interact with and function as transcriptional coactivators of BRCA1
Pao, G. M., Janknecht, R., Ruffner, H., Hunter, T., & Verma, I. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1020 · Cited by 222
Mutations in p53 as potential molecular markers for human breast cancer.
Runnebaum, I. B., Nagarajan, M., Bowman, M., Soto, D., & Sukumar, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10657 · Cited by 222
Beger, C., Pierce, L. N., Krüger, M., Marcusson, E. G., Robbins, J. M., Welcsh, P., Welch, P. J., Welte, K., King, M.-C., Barber, J. R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.130 · Cited by 221
Rajan, J. V., Wang, M., Marquis, S. T., & Chodosh, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13078 · Cited by 219
Location of BRCA1 in Human Breast and Ovarian Cancer Cells
Scully, R., Ganesan, S., Brown, M., De Caprio, J. A., Cannistra, S. A., Feunteun, J., Schnitt, S., & Livingston, D. M. (1996) · Science · doi:10.1126/science.272.5258.123 · Cited by 217
BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor
Zheng, L., Annab, L. A., Afshari, C. A., Lee, W.-H., & Boyer, T. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171174298 · Cited by 212
Transcriptional activation functions in BRCA2
Milner, J., Ponder, B., Hughes-Davies, L., Seltmann, M., & Kouzarides, T. (1997) · Nature · doi:10.1038/386772a0 · Cited by 211
Ye, Q., Hu, Y.-F., Zhong, H., Nye, A. C., Belmont, A. S., & Li, R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108049 · Cited by 206
Chen, C.-F., Li, S., Chen, Y., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32863 · Cited by 203
The GADD45 Inhibition of Cdc2 Kinase Correlates with GADD45-mediated Growth Suppression
Jin, S., Antinore, M. J., Lung, F.-D. T., Dong, X., Zhao, H., Fan, F., Colchagie, A. B., Blanck, P., Roller, P. P., Fornace, A. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000284200 · Cited by 202
Ouchi, T., Lee, S. W., Ouchi, M., Aaronson, S. A., & Horvath, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080469697 · Cited by 201
Lane, T. F., Deng, C., Elson, A., Lyu, M. S., Kozak, C. A., & Leder, P. (1995) · Genes & Development · doi:10.1101/gad.9.21.2712 · Cited by 197
Greenblatt, M. S., Chappuis, P. O., Bond, J. P., Hamel, N., & Foulkes, W. D. (2001) · PubMed · Cited by 196
Sheikh, M. S., Hollander, M. C., & Fornace, A. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00291-9 · Cited by 196
Sewalt, R. G. A. B., Gunster, M. J., van der Vlag, J., Satijn, D. P. E., & Otte, A. P. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.777 · Cited by 195
Wilson, C. A., Payton, M. N., Elliott, G. S., Buaas, F. W., Cajulis, E. E., Grosshans, D., Ramos, L., Reese, D. M., Slamon, D. J., & Calzone, F. J. (1997) · Oncogene · doi:10.1038/sj.onc.1200924 · Cited by 193
Functional Interaction of BRCA1-Associated BARD1 with Polyadenylation Factor CstF-50
Kleiman, F. E., & Manley, J. L. (1999) · Science · doi:10.1126/science.285.5433.1576 · Cited by 193
BRCA1 and BRCA2 mutations in a population-based study of male breast cancer
Basham, V. M., Lipscombe, J. M., Ward, J. M., Gayther, S. A., Ponder, B. A., Easton, D. F., & Pharoah, P. D. (2001) · Breast Cancer Research · doi:10.1186/bcr419 · Cited by 191
Kojima, T., Tanaka, T., & Mori, H. (1994) · PubMed · Cited by 191
Gatei, M., Zhou, B.-B., Hobson, K., Scott, S., Young, D., & Khanna, K. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011681200 · Cited by 191
Xu, B., O’Donnell‐Luria, A., Kim, S., & Kastan, M. B. (2002) · PubMed · Cited by 190
Brodie, S. G., Xu, X., Qiao, W., Li, W.-M., Cao, L., & Deng, C.-X. (2001) · Oncogene · doi:10.1038/sj.onc.1204929 · Cited by 188
Fabbro, M., Rodriguez, J. A., Baer, R., & Henderson, B. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200769200 · Cited by 187
Thai, T. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.195 · Cited by 185
Induction of Estradiol Metabolism by Dietary Indole-3-carbinol in Humans
Michnovicz, J. J., & Bradlow, H. L. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.11.947 · Cited by 181
Chai, Y., Cui, J.-Q., Shao, N., Reddy, E. S. P., & Rao, V. N. (1999) · Oncogene · doi:10.1038/sj.onc.1202323 · Cited by 179
Hormone-dependent regulation of BRCA1 in human breast cancer cells.
Gudas, J. M., Nguyen, H., Li, T., & Cowan, K. H. (1995) · PubMed · Cited by 178
Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer
Dickson, C., Fantl, V., Gillett, C., Brookes, S., Bartek, J., Smith, R., Fisher, C., Barnes, D., & Peters, G. (1995) · Cancer Letters · doi:10.1016/0304-3835(94)03676-a · Cited by 176
Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.
Eisinger, F., Stoppa‐Lyonnet, D., Longy, M., Kerangueven, F., Noguchi, T., Bailly, C., Vincent‐Salomon, A., Jacquemier, J. D., Birnbaum, D., & Sobol, H. (1996) · PubMed · Cited by 171
Chapter 8: Estrogen Receptor-Mediated Processes in Normal and Cancer Cells
Dickson, R. B., & Stancel, G. M. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024237 · Cited by 168
Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains
Jin, Y., Xu, X. L., Yang, M.-C. W., Wei, F., Ayi, T.-C., Bowcock, A. M., & Baer, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12075 · Cited by 162
MacLachlan, T. K., Takimoto, R., & El-Deiry, W. S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4280-4292.2002 · Cited by 160
Rajan, J. V., Marquis, S. T., Gardner, H. P., & Chodosh, L. A. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8526 · Cited by 159
BRCA1-associated growth arrest is RB-dependent
Aprelikova, O. N., Fang, B. S., Meissner, E. G., Cotter, S., Campbell, M., Kuthiala, A., Bessho, M., Jensen, R. A., & Liu, E. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11866 · Cited by 158
Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines.
Fan, S., Meng, Q., Gao, B., Grossman, J., Yadegari, M., Goldberg, I. D., & Rosen, E. M. (2000) · PubMed · Cited by 156
Self-citationOhler, Z. W., Montagna, C., Xu, X., Howard, T. A., Gadina, M., Brodie, S. G., Deng, C., & Ried, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205636 · Cited by 156
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents
Mullan, P. B., Quinn, J. E., Gilmore, P. M., McWilliams, S., Andrews, H. N., Gervin, C., McCabe, N., McKenna, S., White, P., Song, Y., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204712 · Cited by 154
Identification of a Functional Nuclear Export Sequence in BRCA1
Rodríguez, J. A., & Henderson, B. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003851200 · Cited by 153
Yeh, S., Hu, Y., Rahman, M. M., Lin, H., Hsu, C.-L., Ting, H., Kang, H., & Chang, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190353897 · Cited by 151
Preliminary Results of the Use of Indole‐3‐Carbinol for Recurrent Respiratory Papillomatosis
Rosen, C. A., Woodson, G. E., Thompson, J. W., Hengesteg, A., & Bradlow, H. L. (1998) · Otolaryngology · doi:10.1016/s0194-5998(98)70274-8 · Cited by 150
Sum, E. Y. M., Peng, B. H., Yu, X., Chen, J., Byrne, J. A., Lindeman, G. J., & Visvader, J. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110603200 · Cited by 150
p300 Modulates the BRCA1 inhibition of estrogen receptor activity.
Fan, S., Ma, Y. X., Wang, C., Yuan, R., Meng, Q., Wang, J., Erdos, M. R., Goldberg, I. D., Webb, P., Kushner, P. J., et al. (2002) · PubMed · Cited by 148
Self-citationCell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.
Gudas, J. M., Li, T., Nguyen, H., Jensen, D., Rauscher, F. J., & Cowan, K. H. (1996) · PubMed · Cited by 146
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.
Vaughn, J. P., Davis, P. L., Jarboe, M. D., Hüper, G., Evans, A. C., Wiseman, R. W., Berchuck, A., Iglehart, J. D., Futreal, P. A., & Marks, J. R. (1996) · PubMed · Cited by 145
Induction of apoptosis by the tumor suppressor protein BRCA1.
Shao, N., Chai, Y. L., Shyam, E., Reddy, P., & Rao, V. N. (1996) · PubMed · Cited by 137
Meng, Q., Qi, M., Chen, D., Yuan, R., Goldberg, I. D., Rosen, E. M., Auborn, K. J., & Fan, S. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000088 · Cited by 136
Self-citationBRCA1 RING Domain Cancer-predisposing Mutations
Brzović, P. S., Meza, J. E., King, M., & Klevit, R. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106551200 · Cited by 135
Li, H., Lee, T., & Avraham, H. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112231200 · Cited by 134
Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor
McGowan, C. H. (2002) · BioEssays · doi:10.1002/bies.10101 · Cited by 134
Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds.
Neuhausen, S. L., & Marshall, C. J. (1994) · PubMed · Cited by 132
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
Chan, K. Y. K., Özçelik, H., Cheung, A., Ngan, H., & Khoo, U. (2002) · PubMed · Cited by 132
The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis
Takimoto, R., Wang, W., Dicker, D. T., Rastinejad, F., Lyssikatos, J. P., & El‐Deiry, W. S. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.1.41 · Cited by 131
Defining a role for c-Myc in breast tumorigenesis
Nass, S. J., & Dickson, R. B. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005858611585 · Cited by 130
Wang, H., Shao, N., Ding, Q. M., Cui, J., Reddy, E. S. P., & Rao, V. N. (1997) · Oncogene · doi:10.1038/sj.onc.1201252 · Cited by 130
Vaughn, J. P., Cirisano, F. D., Hüper, G., Berchuck, A., Futreal, P. A., Marks, J. R., & Iglehart, J. D. (1996) · PubMed · Cited by 129
Huber, L. J., Yang, T. W., Sarkisian, C. J., Master, S. R., Deng, C., & Chodosh, L. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.4005-4015.2001 · Cited by 126
BRCA1 Regulates GADD45 through Its Interactions with the OCT-1 and CAAT Motifs
Fan, W., Jin, S., Tong, T., Zhao, H., Fan, F., Antinore, M. J., Rajasekaran, B., Wu, M., & Zhan, Q. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110225200 · Cited by 125
Pavelić, Z. P., Pavelić, L., Lower, E. E., Gapany, M., Gapany, S. R., Barker, E. A., & Preisler, H. D. (1992) · PubMed · Cited by 124
Altiok, S., Batt, D. B., Altıok, N., Papautsky, A., Downward, J., Roberts, T. M., & Avraham, H. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32274 · Cited by 120
Cited by
Oxidative stress and cancer: An overview
Sosa, V., Moliné, T., Somoza, R., Paciucci, R., Kondoh, H., & LLeonart, M. E. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.10.004 · Cited by 1,439
Principles of Tumor Suppression
Sherr, C. J. (2004) · Cell · doi:10.1016/s0092-8674(03)01075-4 · Cited by 1,034
Yoshida, K., & Miki, Y. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02195.x · Cited by 753
Oxidative Stress in Cancer Cell Metabolism
Arfin, S., Jha, N. K., Jha, S. K., Kesari, K. K., Ruokolainen, J., Roychoudhury, S., Rathi, B., & Kumar, D. (2021) · Antioxidants · doi:10.3390/antiox10050642 · Cited by 665
Redox Regulation in Cancer: A Double‐edged Sword with Therapeutic Potential
Acharya, A., Das, I., Chandhok, D., & Saha, T. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.1.10095 · Cited by 486
Metadata
- Authors
- Rosen, E. M., Fan, S., Pestell, R. G., & Goldberg, I. D.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2003-03-31
- Volume
- 196
- Issue
- 1
- Pages
- 19-41
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2050376635
- Cited by
- 268
- References
- 275
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.